Abstract
Ten inactivated vaccines containing one of four adjuvants and varying concentrations of pseudorabies virus (PRV) antigens were compared in order to select a vaccine suitable for commercial production. A genetically engineered strain of PRV lacking the gene coding for glycoprotein X (gpX) was used in these vaccines. Vaccinated pigs were challenged intranasally with virulent PRV to determine the efficacy of vaccines. Vaccination of pigs with one dose of experimental vaccines adjuvanted with 50% Montanide ISA 50 or 20% Syntrogen induced a protective immunity at least equal to that induced by two commercially available killed PRV vaccines also evaluated. An experimental vaccine containing 20% Syntrogen was selected and further evaluated according to United States Department of Agriculture licensing requirements. None of the pigs vaccinated with this vaccine produced gpX antibodies detectable by the HerdChek: Anti-PRV-gpX assay. Therefore, this assay could differentiate PRV vaccine induced antibodies from antibodies induced by natural exposure when used in conjunction with this killed gpX deleted PRV vaccine.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Alva-Valdes R., Glock R. D., Kluge J. P., Keune C. M. Effects of vaccination on lesion development in pseudorabies virus-challenged swine. Am J Vet Res. 1983 Apr;44(4):588–595. [PubMed] [Google Scholar]
- Bahnemann H. G. Inactivation of viruses in serum with binary ethyleneimine. J Clin Microbiol. 1976 Feb;3(2):209–210. doi: 10.1128/jcm.3.2.209-210.1976. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Cook D., Hill H., Snyder M., McMahon P., Kinker D. The detection of antibodies to the glycoprotein X antigen of pseudorabies virus. J Vet Diagn Invest. 1990 Jan;2(1):24–28. doi: 10.1177/104063879000200105. [DOI] [PubMed] [Google Scholar]
- Donaldson A. I., Wardley R. C., Martin S., Harkness J. W. Influence of vaccination on Aujeszky's disease virus and disease transmission. Vet Rec. 1984 Aug 11;115(6):121–124. doi: 10.1136/vr.115.6.121. [DOI] [PubMed] [Google Scholar]
- McFerran J. B., Dow C., McCracken R. M. Experimental studies in weaned pigs with three vaccines against Aujeszky's disease. Comp Immunol Microbiol Infect Dis. 1979;2(2-3):327–334. doi: 10.1016/0147-9571(79)90020-1. [DOI] [PubMed] [Google Scholar]
- McFerran J. B., Dow C. Studies on immunisation of pigs with the Bartha strain of Aujeszky's disease virus. Res Vet Sci. 1975 Jul;19(1):17–22. [PubMed] [Google Scholar]
- Platt K. B., Maré C. J., Hinz P. N. Differentiation of vaccine strains and field isolates of pseudorabies (Aujeszky's disease) virus: thermal sensitivity and rabbit virulence markers. Arch Virol. 1979;60(1):13–23. doi: 10.1007/BF01318093. [DOI] [PubMed] [Google Scholar]
- de Leeuw P. W., van Oirschot J. T. Vaccines against Aujeszky's disease: evaluation of their efficacy under standardized laboratory conditions. Vet Q. 1985 Jul;7(3):191–197. doi: 10.1080/01652176.1985.9693982. [DOI] [PubMed] [Google Scholar]